A Placebo-Controlled Elimination Study to Identify Potential Treatment Agents for Cocaine Detoxification

References

• Tennant F. S., Rawson R. A. Cocaine and amphetamine dependence treated with desipramine. Problems of Drug Dependence, L Harris. National Institute on Drug Abuse, Rockville, MD 1983; 351–355
   Google Scholar
• Holden C. Street-wise crack research. Science 1989; 246: 1376–1381
   PubMed Web of Science ®Google Scholar
• Malcolm R., Hutto B. R., Phillips J. D. et al. Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry 1991; 52: 39–40
   PubMed Web of Science ®Google Scholar
• Gawin F. H., Kleber H. D. Cocaine abuse treatment. Arch Gen Psychiatry 1984; 41: 903–909
   PubMed Web of Science ®Google Scholar
• Kosten T. R. Can cocaine craving be a medication development outcome? Drug craving and relapse in opioid and cocaine dependence. American Journal on Addictions 1992; 1: 230–239
   Google Scholar
• Hall W. C., Taibert R. L., Ereshefsky L. Cocaine abuse and its treatment. Pharmacotherapy 1990; 10: 47–65
   PubMed Web of Science ®Google Scholar
• Dackis C. A., Gold M. S. Bromocriptine as a treatment for cocaine abuse. Lancet 1985; 1: 1151–1152
   PubMed Web of Science ®Google Scholar
• Haiikas J. A., Crosby R. D., Carlson G. A. et al. Cocaine reduction in unmotivated crack users using car-bamazepine versus placebo in a short-term double-blind crossover design. Clin Pharmacol Ther 1991; 50: 81–95
   Google Scholar
• Tennant F. Clinical trial of multiple treatment agents for cocaine elimination: a placebo-controlled elimination study. Problems of Drug Dependence, L. Harris. National Institute on Drug Abuse, Rockville, MD 1991; 512–513
   Google Scholar
• Trouve R., Nahas G. G. Antidotes to lethal cocaine toxicity in the rat. Archives of Pharmacodynamic Therapy 1990; 305: 197–207
   Google Scholar
• Nahas G., Trouve R. A calcium-channel blocker as antidote to the cardiac effects of cocaine intoxication. N Engl J Med 1985; 313: 519–520
   Google Scholar
• Trouve R., Nahas G. Nitrendipine: an antidote to cardiac and lethal toxicity of cocaine. Proc Soc Exp Biol Med 1986; 183: 392–397
   PubMed Web of Science ®Google Scholar
• Grebb JA. Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice. Life Sci 1986; 38: 2375–2381
   PubMed Web of Science ®Google Scholar
• Vicaut E., Trouve R., Hou X. Microvascular effects of cocaine: interaction with nitrendipine and en-alaprilat. J Clin Toxicol 1991; 29: 165–175
   Google Scholar
• Poklis A. Evaluation of TDX cocaine metabolite assay. J Anal Toxicol 1987; 11: 228–230
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 3rd Edition, Revised. Washington, DC 1987; 177–179
   Google Scholar
• Kosten T. R., Garvin F. H., Kosten T. A. et al. Six-month follow-up of short-term pharmacotherapy for cocaine dependence. American Journal on Addictions 1992; 1: 40–49
   Google Scholar
• Kosten T. R. Pharmacotherapeutic inventory for cocaine abuse: matching patients to treatments. J Nerv Ment Dis 1989; 177: 379–389
   PubMed Web of Science ®Google Scholar
• Tennant F. S., Shannon J. Quantitative urine testing: a new tool for diagnosing and treating cocaine use. Postgrad Med 1989; 86: 107–114
   PubMed Web of Science ®Google Scholar
• Kranzler H. R., Dellaflora S. S., McLaughlin L. et al. Persistent urinary benzoylecgonine following cocaine use. American Journal on Addictions 1992; 1: 265–271
   Google Scholar
• Weiss R. D., Gawin F. H. Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers. Am J Med 1988; 85: 879–880
   PubMed Web of Science ®Google Scholar
• Cone E. J., Weddington W.W., Jr. Prolonged occurrence of cocaine in human saliva and urine after chronic use. J Anal Toxicol 1989; 13: 65–68
   PubMed Web of Science ®Google Scholar
• Brogan W. C., Lange R. A., Glamann B. et al. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med 1992; 116: 556–561
   PubMed Web of Science ®Google Scholar
• Asghar K. Role of dietary and environmental factors in drug abuse. Alcohol and Drug Research 1986; 7: 61–83
   Google Scholar
• Novielli K. D., Chambers C. V. Splenic infarction after cocaine use. Ann Intern Med, 1991; 114–251
   Google Scholar
• Tang M., Falk J. L. Schedule-induced oral self-administration of cocaine and ethanol solutions: lack of effect of chronic desipramine. Drug Alcohol Depend 1990; 26: 21–25
   Google Scholar
• Mello N. K., Lucas S. E., Bree M. P. et al. Desipramine effects on cocaine self-administration by rhesus monkeys. Drug Alcohol Depend 1990; 26: 103–116
   PubMedGoogle Scholar
• Muramatsu I., Kigoshi S., Oshita M. Noradrenergic nature of prazosin-resistant sympathetic contraction in the dog mesenteric artery. J Pharmacol Exp Ther 1984; 229: 532–538
   PubMedGoogle Scholar
• Accetto B. Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pen-Treatment Agents for Cocaine Detoxification toxifylline: results of double-blind study vs. vasodi-lator-nylidrin. Am Heart J 1982; 103: 864–869
   PubMed Web of Science ®Google Scholar
• Avido D. M., Porter J. M. Pentoxifylline: new drug for treatment of intermittent claudication: mechanism of action, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy 1984; 4: 297–307
   Google Scholar
• Marcus S., Weiner S. R., Suzuki S. M. et al. Reynaud's syndrome: using a range of therapies to help patients. Postgrad Med 1991; 89: 171–187
   Google Scholar
• Peterson P. L., Roszler M., Jacobs I. et al. Neurovascular complications of cocaine abuse. Journal of Neuropsychiatry 1991; 3: 143–149
   PubMedGoogle Scholar
• Freudenberger R. S., Cappell M. S., Hun D. A. Intestinal infarction after intravenous cocaine administration. Ann Intern Med 1990; 113: 715–716
   PubMed Web of Science ®Google Scholar
• Holman B. L., Carvalho P. A., Mendelson J. et al. Brain perfusion is abnormal in cocaine-dependent poly-drug users: a study using Technetium-99m-HMPAO and ASPECT. J Nucl Med 1991; 32: 1206–1210
   PubMed Web of Science ®Google Scholar
• Mathew R. J., Wilson W. H. Substance abuse and cerebral blood flow. Am J Psychiatry 1991; 148: 292–305
   PubMed Web of Science ®Google Scholar
• Creglar I. X., Mark H. Medical complications of cocaine abuse. N Engl J Med 1986; 315: 1495–1499
   Google Scholar
• Volkow N. D., Fowler J. S., Wolf A. P. et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148: 621–626
   PubMed Web of Science ®Google Scholar
• Young S. L., Vosper N. J., Phillips S. A. Cocaine: its effects on maternal and child health. Pharmacotherapy 1992; 12: 2–17
   PubMed Web of Science ®Google Scholar
• Gunne L. M., Jonsson J. Effects of cocaine administration on brain, adrenal, and urinary adrenaline and noradrenaline in rats. Psychopharmacologia 1964; 6: 125–129
   PubMed Web of Science ®Google Scholar
• Singh I. Prolonged oculogyric crisis on addition of nifedipine to neuroleptic medication regime. Br J Psychiatry 1987; 150: 127–128
   Google Scholar
• Tennant P. S., Berman M. L. Stepwise detoxification from cocaine: a promising regimen. Postgrad Med 1988; 84: 225–235
   PubMed Web of Science ®Google Scholar
• Weddington W. W., Jr, Brown B. S., Haertzen C. A. et al. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 1991; 17: 137–152
   PubMed Web of Science ®Google Scholar